The HCS-3DX platform performs automated analysis of three-dimensional cell cultures, known as spheroids. Using AI-based image processing and sample selection, the system enables large-scale, high-precision screening of cellular models within a fraction of the usual time.<\/p>\n
“Our goal was to create a unified platform that integrates the strengths of existing technologies and can be easily implemented in research and industry” said \u00c1kos Di\u00f3sdi, first author of the study.<\/p>\n
According to Dr. P\u00e9ter Horv\u00e1th, director of the Institute of Biochemistry at the HUN-REN Biological Research Centre, Szeged and senior author of the paper:<\/p>\n
“One of the main bottlenecks in personalized medicine has been the limited throughput of cell-based assays. The HCS-3DX system removes this limitation, allowing for fast, large-scale, and highly accurate analysis.”<\/p>\n
The technology is already being tested on clinical samples through a collaboration with the Heidelberg Children’s Hospital, where miniature tumor models derived from pediatric brain cancer patients are used to identify the most effective therapeutic options.<\/p>\n
Source:<\/p>\n
HUN-REN Szegedi Biol\u00f3giai Kutat\u00f3k\u00f6zpont<\/a><\/p>\n Journal reference:<\/p>\n